1. Home
  2. H vs MEDP Comparison

H vs MEDP Comparison

Compare H & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyatt Hotels Corporation

H

Hyatt Hotels Corporation

SELL

Current Price

$170.06

Market Cap

16.8B

ML Signal

SELL

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

SELL

Current Price

$614.45

Market Cap

17.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
H
MEDP
Founded
1957
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8B
17.2B
IPO Year
2009
2016

Fundamental Metrics

Financial Performance
Metric
H
MEDP
Price
$170.06
$614.45
Analyst Decision
Buy
Hold
Analyst Count
25
14
Target Price
$195.96
★ $595.92
AVG Volume (30 Days)
★ 710.3K
229.7K
Earning Date
10-29-2026
10-21-2026
Dividend Yield
★ 0.36%
N/A
EPS Growth
N/A
★ 20.98
EPS
1.53
★ 8.53
Revenue
★ $4,685,000,000.00
N/A
Revenue This Year
$106.37
$12.72
Revenue Next Year
$8.26
$6.33
P/E Ratio
$110.27
★ $73.75
Revenue Growth
★ 5.78
N/A
52 Week Low
$134.18
$373.00
52 Week High
$206.86
$677.90

Technical Indicators

Market Signals
Indicator
H
MEDP
Relative Strength Index (RSI) 61.40 51.43
Support Level $155.49 $570.70
Resistance Level $173.71 $634.72
Average True Range (ATR) 4.09 19.38
MACD 1.69 -0.05
Stochastic Oscillator 72.24 43.83

Price Performance

Historical Comparison
H
MEDP

About H Hyatt Hotels Corporation

Hyatt is an operator of owned (2% of total rooms) and managed and franchised (98%) properties across about 35 upscale luxury brands, which include vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. Regional exposure, as a percentage of total rooms, is 45% for the US, 31% for the rest of the world, and 24% for Asia-Pacific.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: